Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Sep;55(9):1438-44.
doi: 10.2967/jnumed.114.141093. Epub 2014 Jul 28.

Absolute quantitation of myocardial blood flow in human subjects with or without myocardial ischemia using dynamic flurpiridaz F 18 PET

Affiliations

Absolute quantitation of myocardial blood flow in human subjects with or without myocardial ischemia using dynamic flurpiridaz F 18 PET

René R S Packard et al. J Nucl Med. 2014 Sep.

Abstract

Absolute quantitation of myocardial blood flow (MBF) by PET is an established method of analyzing coronary artery disease (CAD) but subject to the various shortcomings of available radiotracers. Flurpiridaz F 18 is a novel PET radiotracer that exhibits properties of an ideal tracer.

Methods: A new absolute perfusion quantitation method with flurpiridaz was developed, taking advantage of the early kinetics and high first-pass extraction by the myocardium of this radiotracer, and the first-in-human measurements of MBF performed in 7 healthy subjects and 8 patients with documented CAD. PET images with time-activity curves were acquired at rest and during adenosine stress.

Results: In healthy subjects, regional MBF between coronary artery territories did not differ significantly, leading to a mean global MBF of 0.73 mL/min/g at rest and 2.53 mL/min/g during stress, with a mean global myocardial flow reserve (MFR) of 3.70. CAD vascular territories with <50% stenosis demonstrated a mean MBF of 0.73 at rest and 2.02 during stress, leading to a mean MFR of 2.97. CAD vascular territories with ≥50% stenosis exhibited a mean MBF of 0.86 at rest and 1.43 during stress, leading to a mean MFR of 1.86. Differences in stress MBF and MFR between normal and CAD territories, as well as between <50% and ≥50% stenosis vascular territories, were significant (P < 0.01).

Conclusion: Absolute quantitation of MBF in humans with the novel PET radiotracer flurpiridaz is feasible over a wide range of cardiac flow in the presence or absence of stress-inducible myocardial ischemia. The significant decrease in stress MBF and ensuing MFR in CAD territories allows a clear distinction between vascular territories exhibiting stress-inducible myocardial ischemia and those with normal perfusion.

Keywords: MBF; MFR; PET; flurpiridaz; human.

PubMed Disclaimer

Conflict of interest statement

DISCLOSURE

The other authors have no potential conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Polar maps in a CAD patient with stress images (A–C) and rest images (D–F) demonstrating a reversible defect affecting mostly the LAD territory. Early summed images (0.5–2 min) were re-oriented into short-axis views (A, D), polar maps generated (B, E), and normalized based on averages of normal subjects (C, F). The vascular territories and the left ventricular chamber were defined on the polar map automatically.
Figure 2
Figure 2
Left ventricular blood pool time-activity curve (TAC) (circle symbols) and Left Anterior Descending Artery TAC (lozenge symbols) obtained from predefined vascular ROI on the polar map during rest (A) and with adenosine stress (B) in a normal subject. The solid curve is the model fit to the vascular territory myocardial TAC based on a single-compartment model.
Figure 3
Figure 3
Regional MBF at rest (RMBF) and during adenosine stress (SMBF) and MFR in the 3 vascular territories of normal subjects.
Figure 4
Figure 4
Regional MBF at rest (RMBF) and during adenosine stress (SMBF) and MFR in vascular territories of normal subjects with low likelihood of myocardial ischemia vs. vascular territories of CAD patients with < 50% stenosis and ≥ 50% stenosis.
Figure 5
Figure 5
Scatterplot of the MFR obtained from each individual territory in normal subjects with low likelihood of myocardial ischemia vs. CAD patients with < 50% stenosis and ≥ 50% stenosis.

References

    1. Schindler TH, Schelbert HR, Quercioli A, Dilsizian V. Cardiac PET imaging for the detection and monitoring of coronary artery disease and microvascular health. JACC Cardiovascular imaging. 2010 Jun;3(6):623–640. - PubMed
    1. Maddahi J. Properties of an ideal PET perfusion tracer: new PET tracer cases and data. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology. 2012 Feb;19(Suppl 1):S30–S37. - PubMed
    1. Yalamanchili P, Wexler E, Hayes M, et al. Mechanism of uptake and retention of F-18 BMS-747158-02 in cardiomyocytes: a novel PET myocardial imaging agent. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology. 2007 Nov-Dec;14(6):782–788. - PubMed
    1. Yu M, Guaraldi MT, Mistry M, et al. BMS-747158-02: a novel PET myocardial perfusion imaging agent. Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology. 2007 Nov-Dec;14(6):789–798. - PubMed
    1. Huisman MC, Higuchi T, Reder S, et al. Initial characterization of an 18F-labeled myocardial perfusion tracer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2008 Apr;49(4):630–636. - PubMed

Publication types